Scholarly Index
Corinne Antignac
Inserm; 30,029 total citations; 382 total publications; best world rank #14
Inserm
30,029Total citations
382Total publications
102H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal Diseases and Glomerulopathies | Lifetime | 37 | FR 4 | 99.61 |
| Biomedical Research and Pathophysiology | Lifetime | 14 | FR 1 | 99.13 |
| Genetic and Kidney Cyst Diseases | Lifetime | 30 | FR 2 | 99.22 |
| Renal and related cancers | Lifetime | 79 | FR 4 | 99.43 |
| Neonatal Health and Biochemistry | Lifetime | 178 | FR 7 | 98.14 |
| Cell Adhesion Molecules Research | Lifetime | 554 | FR 15 | 98.29 |
| Amino Acid Enzymes and Metabolism | Lifetime | 491 | FR 6 | 96.76 |
| Platelet Disorders and Treatments | Lifetime | 814 | FR 55 | 96.29 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 706 | FR 28 | 95.31 |
| Chronic Kidney Disease and Diabetes | Lifetime | 958 | FR 19 | 95.23 |
| Ion Transport and Channel Regulation | Lifetime | 730 | FR 32 | 94.47 |
| Genetic Syndromes and Imprinting | Lifetime | 975 | FR 48 | 91.78 |
| Tuberous Sclerosis Complex Research | Lifetime | 953 | FR 31 | 75.82 |
| Biomedical Research and Pathophysiology | 2021-2025 | 630 | FR 30 | 42.90 |
| Caveolin-1 and cellular processes | 2021-2025 | 459 | FR 11 | 27.95 |